Kala Pharmaceuticals Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor
5/6/2013 10:04:39 AM
More...
|
Kala Pharmaceuticals to Present Data at Association for Research in Vision & Ophthalmology 2013 Annual Meeting
5/3/2013 7:56:22 AM
More...
|
Kala Pharmaceuticals Appoints Kim Brazzell, Ph.D., as Chief Medical Officer
2/28/2013 11:19:11 AM
More...
|
Kala Pharmaceuticals Secures $11.5 Million in Series A Financing
2/28/2013 6:58:43 AM
More...
|
Kala Pharmaceuticals Receives Cystic Fibrosis Foundation Grant
2/5/2013 10:46:32 AM
More...
|
Kala Pharmaceuticals Co-founder Publishes Data on Novel Therapeutic Approach to Overcome Mucosal Barrier for Prevention of Herpes Simplex Virus-2 Infection
7/12/2012 10:27:53 AM
More...
|
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
7/12/2012 8:10:38 AM
More...
|
Kala Pharmaceuticals Gets National Institutes of Health (NIH) Grants, Raises $6.2 Million
3/14/2012 6:54:40 AM
More...
|